Contest Trader

Don't miss the chance to cash-in prizes totaling

$10.000
Register here for the Ultimate demo trading competition

Stocks keep on gaining - Wednesday Review, November 11

Stocks keep on gaining - Wednesday Review, November 11

The potential COVID-19 vaccine moved the markets for the third consecutive day

The US

The benchmarks traded mixedly, part of them reacting to the fact that new restrictions might be imposed to curb the spread of COVID-19. On the other hand, others were driven by Microsoft and Apple's success following the launch of their new products. USA30 fell 0.08%, while USA500 gained 0.78%. TECH100 added 2.01%.

Crude settled up 1.5% at $41.99 per barrel. Brent rose 1% at $44.05.

Gold settled down 0.8% at $1,861.40 per ounce.

The Dollar Index traded at 92.741.

Asia and Australia

The markets closed higher over optimism that a viable COVID-19 vaccine could be successfully developed and launched. HongKong45 gained 2.24%.

Japan225 rose 5.41%.

Down under, Australia200 traded 1.79% higher.

Europe

Pfizer's potential COVID-19 still impacted the markets. Also, Europe was looking forward to Christine Lagarde's speech regarding the economic outlook and stimulus prospects. Europe50 climbed 0.4%. Germany30hit a one-month high after adding 0.56%. France40 went up 0.4%, while UK100 closed 0.2% higher.

EUR/USD closed at 1.1827 after it gained 0.1%.

Sources: investing.com, reuters.com

This information prepared by za.capex.com is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.

This information is prepared for general circulation. It does not regard to the specific investment objectives, financial situation or the particular needs of any recipient.

You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.

This information may not be published, circulated, reproduced or distributed in whole or in part to any other person without the Company’s prior written consent. Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of za.capex.com